Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Canada's 2024 Federal Budget increases capital gains tax

<< Previous

Bullboard Posts

Next >>

Comment by canadafanon Apr 21, 2024 5:02pm

89 Views

Post# 36000396

RE:RE:RE:RE:RE:RE:Canada's 2024 Federal Budget increases capital gains tax

Respectfully, please go back & read the rules.
i5 is based on over $250,000/ year.
There are lifetime exemptions, are one issue.
the tax rules change applies to capital gains in excess of $250k/ year.
you do a lot or reading & resurch.
please look that one up.
and, you do have a point. This is afterall an Onc site. So my math applies to Onc shares, which was the original context of th3 thread.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario